Wall Street’s Great Rotation
For most of this year, US markets were hitting fresh highs and investors were giddy about the potential of AI to make the world’s biggest tech companies even more profitable. Then, the picture changed. Welcome to the Great Rotation. On today’s Big Take podcast, host Sarah Holder speaks to Bloomberg cross-asset reporter Isabelle Lee about what’s behind the investor move from the Magnificent Seven tech firms into smaller companies — and what role, if any, recent US political turmoil is playing in investors’ expectations about the rest of the year. Read more: Markets Tear Up Popular Trades That Reached ‘Stupid Levels’ and Stocks Caught in Tug of War Between Tech and Rest: Markets WrapSee omnystudio.com/listener for privacy information.
26 Juli 202416min
Why You’ll Want to Know How Your Nurse Practitioner Was Trained
Americans are more and more likely to get health care not from doctors, but from nurse practitioners. It’s one of the fastest-growing professions in the US — and the number of nurse practitioners in the country is expected to climb 45% by 2032. But training for the booming profession has never been standardized, and some students worry they’re not being set up for success. On today’s Big Take podcast, host Sarah Holder talks to investigative reporters Caleb Melby and Polly Mosendz about what the rapid rise of nurse practitioners has meant for their education — and their patients. Read more: The Miseducation of America’s Nurse PractitionersSee omnystudio.com/listener for privacy information.
24 Juli 202417min
Are Cheaper Ozempic Knockoffs Safe?
Cheaper, knockoff versions of Ozempic, Wegovy and Zepbound are flooding the market, often promoted by telehealth companies in online ads and by influencers on TikTok and Instagram. These versions of the drugs are made by so-called compounding pharmacies, an obscure corner of America’s pharmaceutical market which makes drugs that aren’t approved by the Food and Drug Administration. On today’s Big Take podcast, Bloomberg reporters Ike Swetlitz and Madison Muller tell host Sarah Holder about their investigation into a $1 billion shadow industry that could be putting Americans’ health in danger. Read more: Unsafe Ozempic Knockoffs Are Flooding the MarketSee omnystudio.com/listener for privacy information.
23 Juli 202416min
Roblox: The Gaming Platform With a Predator Problem
With tens of millions of users under the age of 13, Roblox has become the biggest online gaming playground for kids. The company says its combination of AI chat filters and human moderators makes the platform safe for users of all ages. But a Bloomberg Businessweek investigation suggests that Roblox may have striking vulnerabilities. On today’s Big Take podcast, host David Gura speaks with reporters Olivia Carville and Cecilia D’Anastasio about the way predators have used the platform to groom children — and what Roblox is doing to keep young users safe.See omnystudio.com/listener for privacy information.
22 Juli 202418min
K-Pop’s Plan for Global Dominance? Remove the K
Is K-pop even K-pop without the K? A Bloomberg analysis of song lyrics shows that for the first time, almost half of K-pop songs released this year have English lyrics. On today’s podcast, host Sarah Holder speaks with Bloomberg reporter Sohee Kim about the genre’s identity shift and why industry efforts to grow its global audience might mean fewer Korean band members.See omnystudio.com/listener for privacy information.
19 Juli 202414min
Silicon Valley’s Shift to the Right
Republican presidential nominee Donald Trump’s pick of Senator JD Vance as his running mate has many in Silicon Valley rejoicing — they see the former venture capitalist as one of their own. With Elon Musk’s commitment of $45 million a month to a super-PAC supporting the Trump campaign, it's the latest sign of Silicon Valley elites embracing the MAGA movement. But the tech world hasn’t always embraced Trump. On today’s Big Take podcast, Bloomberg Businessweek columnist Max Chafkin joins host David Gura to talk about how we got here and what their support could mean for another Trump term.See omnystudio.com/listener for privacy information.
18 Juli 202417min
Why This Nobel Winner Faces Life In Prison In Bangladesh
Nobel Peace Prize-winning economist Muhammad Yunus pioneered micro loans as a tool to fight poverty. Now prosecutors in Bangladesh have linked him and his colleagues to a dizzying number of crimes, including embezzlement and laundering millions of dollars. Today on The Big Take, host K. Oanh Ha speaks to Bloomberg’s Kai Schultz about the complicated saga and what implications Yunus’s case has for Bangladesh, one of the fastest growing economies. We also hear from Yunus himself, who talks about the rift between him and Prime Minister Sheikh Hasina, and the personal impact of the legal drama. Read more: Bangladesh Sentences Nobel Peace Prize Winner to 6 Months in Prison Big Money Backs Tiny Loans That Lead to Debt, Despair and Even SuicideSee omnystudio.com/listener for privacy information.
17 Juli 202415min
Pulling Off a Rare Olympic Feat in Paris: Turning a Profit
Ever since the first Olympics were held over a century ago, the Games have been known for dazzling sporting feats…and dazzlingly expensive opening ceremonies. Recently, the ballooning cost of hosting the Games has led residents in Boston, Rome, and Oslo to reject efforts to bring the Olympics to their cities. As a result, the International Olympic Committee is hoping to rein in costs – starting with Paris. On today’s podcast, host Sarah Holder speaks with Bloomberg reporter Hugo Miller about the lessons Paris 2024 is trying to take from the first and only profitable Olympics held in Los Angeles in 1984 – and why no less than the future of the Games is at stake. Read more: Faster, Higher — Cheaper? Paris's Budget Effort to Reboot the OlympicsSee omnystudio.com/listener for privacy information.
12 Juli 202414min
